FDA Issues Draft Guidance on Nanomaterial Drug Development

Drug Industry Daily
A A
The FDA released a draft guidance for the development of drugs that use nanomaterials, stating the importance of describing and analyzing nanomaterials and their attributes in a product’s finished form.

To View This Article:

Login

Subscribe To Drug Industry Daily